{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:13:28Z","timestamp":1793502808587,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The endocannabinoid system (ECS) plays a critical role in fear learning and maintenance and may, therefore, be implicated in the pathophysiology of posttraumatic stress disorder (PTSD). The exact role of cannabinoid receptor 1 (CB1R), a key component of the ECS, remains unclear. Although preclinical studies largely suggest CB1R downregulation in PTSD, the only prior study of CB1R availability in individuals with PTSD reported higher levels than in controls. In this study, we investigated the relationship between CB1R availability and PTSD diagnosis and symptoms. Using positron emission tomography (PET) with the CB1R-specific radiotracer [<jats:sup>11<\/jats:sup>C]OMAR, scans from 62 individuals, including 46 trauma-exposed participants (19 with current PTSD) and 16 healthy controls, were analyzed. Our findings revealed no differences in CB1R availability between groups in either the whole brain or regions of interest. However, emotional numbing symptoms of PTSD were significantly linked to CB1R availability. These results suggest that the ECS role in the maintenance of PTSD is more nuanced than previously suggested. The ECS was linked to specific PTSD symptom expression, highlighting the potential for treatments targeting the ECS in mitigating these specific symptoms of this multi-faceted disorder.<\/jats:p>","DOI":"10.1038\/s41398-025-03519-9","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T20:54:08Z","timestamp":1755896048000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cannabinoid 1 receptor availability in posttraumatic stress disorder: A positron emission tomography study"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1859-2668","authenticated-orcid":false,"given":"Nachshon","family":"Korem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3890-3518","authenticated-orcid":false,"given":"Anahita","family":"Bassir Nia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8105-1381","authenticated-orcid":false,"given":"Ansel T.","family":"Hillmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3141-1462","authenticated-orcid":false,"given":"Deepak","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8129-0051","authenticated-orcid":false,"given":"Nabeel","family":"Nabulsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Ropchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1351-9576","authenticated-orcid":false,"given":"Kelly","family":"Cosgrove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7851-9070","authenticated-orcid":false,"given":"Ifat","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Pietrzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6066-9406","authenticated-orcid":false,"given":"Ilan","family":"Harpaz-Rotem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"3519_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5\u00ae). Arlington, VA: American Psychiatric Publishing; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"3519_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/npp.2017.162","volume":"43","author":"MN Hill","year":"2018","unstructured":"Hill MN, Campolongo P, Yehuda R, Patel S. Integrating endocannabinoid signaling and cannabinoids into the biology and treatment of posttraumatic stress disorder. Neuropsychopharmacology. 2018;43:80\u2013102.","journal-title":"Neuropsychopharmacology"},{"key":"3519_CR3","doi-asserted-by":"crossref","unstructured":"O\u2019Brien K, Blair P The endocannabinoid system, stress, and mental health. In: O\u2019Brien K, Blair P, editors. Med cannabis CBD ment healthc, Cham: Springer International Publishing; 2021. p. 57\u201388.","DOI":"10.1007\/978-3-030-78559-8_3"},{"key":"3519_CR4","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/S0196-9781(00)00324-7","volume":"21","author":"G Moldrich","year":"2000","unstructured":"Moldrich G, Wenger T. Localization of the CB1 cannabinoid receptor in the rat brain. An immunohistochemical study\u2606. Peptides. 2000;21:1735\u201342.","journal-title":"Peptides"},{"key":"3519_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0306-4522(96)00428-9","volume":"77","author":"M Glass","year":"1997","unstructured":"Glass M, Faull RLM, Dragunow M. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience. 1997;77:299\u2013318.","journal-title":"Neuroscience"},{"key":"3519_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1515\/jbcpp-2015-0058","volume":"27","author":"N Korem","year":"2016","unstructured":"Korem N, Zer-Aviv TM, Ganon-Elazar E, Abush H, Akirav I. Targeting the endocannabinoid system to treat anxiety-related disorders. J Basic Clin Physiol Pharmacol. 2016;27:193\u2013202.","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"3519_CR7","doi-asserted-by":"publisher","first-page":"247054702211072","DOI":"10.1177\/24705470221107290","volume":"6","author":"NA Leen","year":"2022","unstructured":"Leen NA, de Weijer AD, van Rooij SJH, Kennis M, Baas JMP, Geuze E. The role of the endocannabinoids 2-AG and anandamide in clinical symptoms and treatment outcome in veterans with PTSD. Chronic Stress. 2022;6:24705470221107290.","journal-title":"Chronic Stress"},{"key":"3519_CR8","first-page":"607","volume":"6","author":"H-C Lu","year":"2021","unstructured":"Lu H-C, Mackie K. Review of the endocannabinoid system. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021;6:607\u201315.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"3519_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.pnpbp.2017.04.004","volume":"85","author":"NB Worley","year":"2018","unstructured":"Worley NB, Hill MN, Christianson JP. Prefrontal endocannabinoids, stress controllability and resilience: a hypothesis. Prog Neuropsychopharmacol Biol Psychiatry. 2018;85:180\u20138.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3519_CR10","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.biopsych.2017.03.002","volume":"82","author":"G Bedse","year":"2017","unstructured":"Bedse G, Hartley ND, Neale E, Gaulden AD, Patrick TA, Kingsley PJ, et al. Functional redundancy between canonical endocannabinoid signaling systems in the modulation of anxiety. Biol Psychiatry. 2017;82:488\u201399.","journal-title":"Biol Psychiatry"},{"key":"3519_CR11","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1186\/1744-8069-5-59","volume":"5","author":"DR Sagar","year":"2009","unstructured":"Sagar DR, Gaw AG, Okine BN, Woodhams SG, Wong A, Kendall DA, et al. Dynamic regulation of the endocannabinoid system: implications for analgesia. Mol Pain. 2009;5:1744\u20138069-5\u201359.","journal-title":"Mol Pain"},{"key":"3519_CR12","first-page":"60","volume":"1","author":"DC D\u2019Souza","year":"2016","unstructured":"D\u2019Souza DC, Cortes-Briones JA, Ranganathan M, Thurnauer H, Creatura G, Surti T, et al. Rapid changes in cannabinoid 1 receptor availability in cannabis-dependent male subjects after abstinence from cannabis. Biol Psychiatry Cogn Neurosci Neuroimaging. 2016;1:60\u201367.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"3519_CR13","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.bbr.2009.05.013","volume":"203","author":"CG Reich","year":"2009","unstructured":"Reich CG, Taylor ME, McCarthy MM. Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats. Behav Brain Res. 2009;203:264\u20139.","journal-title":"Behav Brain Res"},{"key":"3519_CR14","doi-asserted-by":"publisher","first-page":"e13061","DOI":"10.1111\/adb.13061","volume":"26","author":"TR Spindle","year":"2021","unstructured":"Spindle TR, Kuwabara H, Eversole A, Nandi A, Vandrey R, Antoine DG, et al. Brain imaging of cannabinoid type I (CB1) receptors in women with cannabis use disorder and male and female healthy controls. Addict Biol. 2021;26:e13061.","journal-title":"Addict Biol"},{"key":"3519_CR15","doi-asserted-by":"crossref","unstructured":"Zoellner LA, Ojalehto HJ, Rosencrans P, Walker RW, Garcia NM, Sheikh IS, et al. Anxiety and fear in PTSD. In: Emotions in posttraumatic stress disorder. Amsterdam: Elsevier; 2020. p. 43\u201363.","DOI":"10.1016\/B978-0-12-816022-0.00002-8"},{"key":"3519_CR16","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/mp.2013.61","volume":"18","author":"A Neumeister","year":"2013","unstructured":"Neumeister A, Normandin MD, Pietrzak RH, Piomelli D, Zheng M-Q, Gujarro-Anton A, et al. Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. Mol Psychiatry. 2013;18:1034\u201340.","journal-title":"Mol Psychiatry"},{"key":"3519_CR17","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1038\/npp.2014.132","volume":"39","author":"N Korem","year":"2014","unstructured":"Korem N, Akirav I. Cannabinoids prevent the effects of a footshock followed by situational reminders on emotional processing. Neuropsychopharmacology. 2014;39:2709\u201322.","journal-title":"Neuropsychopharmacology"},{"key":"3519_CR18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.nlm.2017.08.004","volume":"144","author":"N Shoshan","year":"2017","unstructured":"Shoshan N, Akirav I. The effects of cannabinoid receptors activation and glucocorticoid receptors deactivation in the amygdala and hippocampus on the consolidation of a traumatic event. Neurobiol Learn Mem. 2017;144:248\u201358.","journal-title":"Neurobiol Learn Mem"},{"key":"3519_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neulet.2012.11.016","volume":"533","author":"AC Campos","year":"2013","unstructured":"Campos AC, Ferreira FR, da Silva WA Jr, Guimar\u00e3es FS. Predator threat stress promotes long lasting anxiety-like behaviors and modulates synaptophysin and CB1 receptors expression in brain areas associated with PTSD symptoms. Neurosci Lett. 2013;533:34\u201338.","journal-title":"Neurosci Lett"},{"key":"3519_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.neulet.2011.05.013","volume":"502","author":"G Xing","year":"2011","unstructured":"Xing G, Carlton J, Zhang L, Jiang X, Fullerton C, Li H, et al. Cannabinoid receptor expression and phosphorylation are differentially regulated between male and female cerebellum and brain stem after repeated stress: implication for PTSD and drug abuse. Neurosci Lett. 2011;502:5\u20139.","journal-title":"Neurosci Lett"},{"key":"3519_CR21","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/sj.npp.1300601","volume":"30","author":"MN Hill","year":"2005","unstructured":"Hill MN, Patel S, Carrier EJ, Rademacher DJ, Ormerod BK, Hillard CJ, et al. Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. Neuropsychopharmacology. 2005;30:508\u201315.","journal-title":"Neuropsychopharmacology"},{"key":"3519_CR22","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1111\/j.1471-4159.2008.05567.x","volume":"106","author":"MN Hill","year":"2008","unstructured":"Hill MN, Carrier EJ, McLaughlin RJ, Morrish AC, Meier SE, Hillard CJ, et al. Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment. J Neurochem. 2008;106:2322\u201336.","journal-title":"J Neurochem"},{"key":"3519_CR23","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/hipo.20537","volume":"19","author":"J Su\u00e1rez","year":"2009","unstructured":"Su\u00e1rez J, Llorente R, Romero\u2010Zerbo SY, Mateos B, Berm\u00fadez\u2010Silva FJ, de Fonseca FR, et al. Early maternal deprivation induces gender\u2010dependent changes on the expression of hippocampal CB1 and CB2 cannabinoid receptors of neonatal rats. Hippocampus. 2009;19:623\u201332.","journal-title":"Hippocampus"},{"key":"3519_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1101\/lm.041608.116","volume":"23","author":"S Alteba","year":"2016","unstructured":"Alteba S, Korem N, Akirav I. Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood. Learn Mem. 2016;23:349\u201358.","journal-title":"Learn Mem"},{"key":"3519_CR25","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1016\/j.psyneuen.2013.08.004","volume":"38","author":"MN Hill","year":"2013","unstructured":"Hill MN, Bierer LM, Makotkine I, Golier JA, Galea S, McEwen BS, et al. Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks. Psychoneuroendocrinology. 2013;38:2952\u201361.","journal-title":"Psychoneuroendocrinology"},{"key":"3519_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.pnpbp.2016.01.004","volume":"67","author":"B Yi","year":"2016","unstructured":"Yi B, Nichiporuk I, Nicolas M, Schneider S, Feuerecker M, Vassilieva G, et al. Reductions in circulating endocannabinoid 2-arachidonoylglycerol levels in healthy human subjects exposed to chronic stressors. Prog Neuropsychopharmacol Biol Psychiatry. 2016;67:92\u201397.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3519_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00406-013-0470-8","volume":"264","author":"C Schaefer","year":"2014","unstructured":"Schaefer C, Enning F, Mueller JK, Bumb JM, Rohleder C, Odorfer TM, et al. Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disorders. Eur Arch Psychiatry Clin Neurosci. 2014;264:459\u201363.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"3519_CR28","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1001\/jamapsychiatry.2019.1427","volume":"76","author":"F Borgan","year":"2019","unstructured":"Borgan F, Laurikainen H, Veronese M, Marques TR, Haaparanta-Solin M, Solin O, et al. In vivo availability of cannabinoid 1 receptor levels in patients with first-episode psychosis. JAMA Psychiatry. 2019;76:1074\u201384.","journal-title":"JAMA Psychiatry"},{"key":"3519_CR29","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1523\/JNEUROSCI.0849-13.2014","volume":"34","author":"J Ceccarini","year":"2014","unstructured":"Ceccarini J, Hompes T, Verhaeghen A, Casteels C, Peuskens H, Bormans G, et al. Changes in cerebral CB1 receptor availability after acute and chronic alcohol abuse and monitored abstinence. J Neurosci. 2014;34:2822\u201331.","journal-title":"J Neurosci"},{"key":"3519_CR30","doi-asserted-by":"publisher","first-page":"e223555","DOI":"10.1001\/jamanetworkopen.2022.3555","volume":"5","author":"O Duek","year":"2022","unstructured":"Duek O, Spiller TR, Rubenstein A, Pietrzak RH, Harpaz-Rotem I. Exploration of a novel model of intrusive symptoms in posttraumatic stress disorder among US Veterans. JAMA Netw Open. 2022;5:e223555.","journal-title":"JAMA Netw Open"},{"key":"3519_CR31","unstructured":"First MB, Williams JB, Karg RS, Spitzer RL User\u2019s guide for the SCID-5-CV structured clinical interview for DSM-5\u00ae disorders: clinical version. Arlington, VA: American Psychiatric Publishing; 2016."},{"key":"3519_CR32","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1037\/pas0000486","volume":"30","author":"FW Weathers","year":"2018","unstructured":"Weathers FW, Bovin MJ, Lee DJ, Sloan DM, Schnurr PP, Kaloupek DG, et al. The clinician-administered PTSD scale for DSM\u20135 (CAPS-5): development and initial psychometric evaluation in military veterans. Psychol Assess. 2018;30:383.","journal-title":"Psychol Assess"},{"key":"3519_CR33","first-page":"1689","volume":"47","author":"AG Horti","year":"2006","unstructured":"Horti AG, Fan H, Kuwabara H, Hilton J, Ravert HT, Holt DP, et al. 11C-JHU75528: a radiotracer for PET imaging of CB1 cannabinoid receptors. J Nucl Med. 2006;47:1689\u201396.","journal-title":"J Nucl Med"},{"key":"3519_CR34","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/jcbfm.2015.46","volume":"35","author":"MD Normandin","year":"2015","unstructured":"Normandin MD, Zheng M-Q, Lin K-S, Mason NS, Lin S-F, Ropchan J, et al. Imaging the cannabinoid CB1 receptor in humans with [11C] OMAR: assessment of kinetic analysis methods, test\u2013retest reproducibility, and gender differences. J Cereb Blood Flow Metab. 2015;35:1313\u201322.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3519_CR35","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0969-8051(00)00125-6","volume":"27","author":"J Hilton","year":"2000","unstructured":"Hilton J, Yokoi F, Dannals RF, Ravert HT, Szabo Z, Wong DF. Column-switching HPLC for the analysis of plasma in PET imaging studies. Nucl Med Biol. 2000;27:627\u201330.","journal-title":"Nucl Med Biol"},{"key":"3519_CR36","doi-asserted-by":"crossref","unstructured":"Carson RE, Barker WC, Liow J-S, Johnson CA Design of a motion-compensation OSEM list-mode algorithm for resolution-recovery reconstruction for the HRRT. In 2003 IEEE Nucl Sci Symp Conf Rec IEEE Cat No 03CH37515, vol. 5 Piscataway, NJ: IEEE; 2003. p. 3281\u20135.","DOI":"10.1109\/NSSMIC.2003.1352597"},{"key":"3519_CR37","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1361-8415(01)00036-6","volume":"5","author":"M Jenkinson","year":"2001","unstructured":"Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal. 2001;5:143\u201356.","journal-title":"Med Image Anal"},{"key":"3519_CR38","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/nimg.2001.0978","volume":"15","author":"N Tzourio-Mazoyer","year":"2002","unstructured":"Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage. 2002;15:273\u201389.","journal-title":"NeuroImage"},{"key":"3519_CR39","first-page":"209","volume":"2006","author":"X Papademetris","year":"2006","unstructured":"Papademetris X, Jackowski MP, Rajeevan N, DiStasio M, Okuda H, Constable RT, et al. BioImage Suite: an integrated medical image analysis suite: an update. Insight J. 2006;2006:209.","journal-title":"Insight J"},{"key":"3519_CR40","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","volume":"27","author":"RB Innis","year":"2007","unstructured":"Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27:1533\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3519_CR41","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1097\/01.WCB.0000038000.34930.4E","volume":"22","author":"M Ichise","year":"2002","unstructured":"Ichise M, Toyama H, Innis RB, Carson RE. Strategies to improve neuroreceptor parameter estimation by linear regression analysis. J Cereb Blood Flow Metab. 2002;22:1271\u201381.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3519_CR42","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/sjos.12611","volume":"50","author":"JAA Andrade","year":"2023","unstructured":"Andrade JAA. On the robustness to outliers of the Student-t process. Scand J Stat. 2023;50:725\u201349.","journal-title":"Scand J Stat"},{"key":"3519_CR43","unstructured":"McElreath R Rethinking: statistical rethinking book package. R Package Version 1.391. 2014 Available from: https:\/\/github.com\/rmcelreath\/rethinking (Accessed 13 Aug 2025)."},{"key":"3519_CR44","doi-asserted-by":"crossref","unstructured":"McElreath R Statistical rethinking: a Bayesian course with examples in R and Stan. Boca Raton, FL: Chapman and Hall\/CRC; 2018.","DOI":"10.1201\/9781315372495"},{"key":"3519_CR45","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1038\/s41386-022-01405-2","volume":"47","author":"N Korem","year":"2022","unstructured":"Korem N, Duek O, Ben-Zion Z, Kaczkurkin AN, Lissek S, Orederu T, et al. Emotional numbing in PTSD is associated with lower amygdala reactivity to pain. Neuropsychopharmacology. 2022;47:1913\u201321.","journal-title":"Neuropsychopharmacology"},{"key":"3519_CR46","doi-asserted-by":"publisher","first-page":"e1516","DOI":"10.7717\/peerj-cs.1516","volume":"9","author":"O Abril-Pla","year":"2023","unstructured":"Abril-Pla O, Andreani V, Carroll C, Dong L, Fonnesbeck CJ, Kochurov M, et al. PyMC: a modern, and comprehensive probabilistic programming framework in Python. PeerJ Comput Sci. 2023;9:e1516.","journal-title":"PeerJ Comput Sci"},{"key":"3519_CR47","doi-asserted-by":"crossref","unstructured":"Kumar R, Carroll C, Hartikainen A, Mart\u00edn OA ArviZ: a unified library for exploratory analysis of Bayesian models in Python. 2019 Available from: https:\/\/arviz-devs.github.io\/arviz\/ (Accessed 13 Aug 2025).","DOI":"10.21105\/joss.01143"},{"key":"3519_CR48","doi-asserted-by":"publisher","first-page":"e2432387","DOI":"10.1001\/jamanetworkopen.2024.32387","volume":"7","author":"N Korem","year":"2024","unstructured":"Korem N, Hillmer AT, D\u2019Souza DC, Nia AB, Levy I, Pietrzak RH, et al. Amygdala cannabinoid 1 receptor, pain response, and emotional numbing in trauma-exposed individuals. JAMA Netw Open. 2024;7:e2432387.","journal-title":"JAMA Netw Open"},{"key":"3519_CR49","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3934\/Neuroscience.2021022","volume":"8","author":"Y Rehman","year":"2021","unstructured":"Rehman Y, Saini A, Huang S, Sood E, Gill R, Yanikomeroglu S. Cannabis in the management of PTSD: a systematic review. AIMS Neurosci. 2021;8:414.","journal-title":"AIMS Neurosci"},{"key":"3519_CR50","doi-asserted-by":"publisher","first-page":"332","DOI":"10.7326\/M17-0477","volume":"167","author":"ME O\u2019Neil","year":"2017","unstructured":"O\u2019Neil ME, Nugent SM, Morasco BJ, Freeman M, Low A, Kondo K, et al. Benefits and harms of plant-based cannabis for posttraumatic stress disorder. Ann Intern Med. 2017;167:332\u201340.","journal-title":"Ann Intern Med"},{"key":"3519_CR51","doi-asserted-by":"publisher","first-page":"108254","DOI":"10.1016\/j.jsat.2020.108254","volume":"122","author":"JL Bryan","year":"2021","unstructured":"Bryan JL, Hogan J, Lindsay JA, Ecker AH. Cannabis use disorder and post-traumatic stress disorder: the prevalence of comorbidity in veterans of recent conflicts. J Subst Abuse Treat. 2021;122:108254.","journal-title":"J Subst Abuse Treat"},{"key":"3519_CR52","doi-asserted-by":"publisher","first-page":"108416","DOI":"10.1016\/j.neuropharm.2020.108416","volume":"184","author":"A Mart\u00edn-S\u00e1nchez","year":"2021","unstructured":"Mart\u00edn-S\u00e1nchez A, Garc\u00eda-Baos A, Castro-Zavala A, Alegre-Zurano L, Valverde O. Early-life stress exacerbates the effects of WIN55,212-2 and modulates the cannabinoid receptor type 1 expression. Neuropharmacology. 2021;184:108416.","journal-title":"Neuropharmacology"},{"key":"3519_CR53","doi-asserted-by":"publisher","first-page":"e246813","DOI":"10.1001\/jamanetworkopen.2024.6813","volume":"7","author":"N Korem","year":"2024","unstructured":"Korem N, Duek O, Spiller T, Ben-Zion Z, Levy I, Harpaz-Rotem I. Emotional state transitions in trauma-exposed individuals with and without posttraumatic stress disorder. JAMA Netw Open. 2024;7:e246813.","journal-title":"JAMA Netw Open"},{"key":"3519_CR54","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jad.2023.07.036","volume":"339","author":"N Korem","year":"2023","unstructured":"Korem N, Ben-Zion Z, Spiller TR, Duek OA, Harpaz-Rotem I, Pietrzak RH. Correlates of avoidance coping in trauma-exposed US military veterans: results from the National Health and Resilience in Veterans Study. J Affect Disord. 2023;339:89\u201397.","journal-title":"J Affect Disord"},{"key":"3519_CR55","doi-asserted-by":"publisher","first-page":"247054702110110","DOI":"10.1177\/24705470211011075","volume":"5","author":"N Korem","year":"2021","unstructured":"Korem N, Duek O, Xu K, Harpaz-Rotem I, Pietrzak RH. Cannabinoid receptor 1 rs1049353 variant, childhood abuse, and the heterogeneity of PTSD symptoms: results from the National Health and Resilience in Veterans Study. Chronic Stress. 2021;5:24705470211011075.","journal-title":"Chronic Stress"},{"key":"3519_CR56","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jad.2011.02.017","volume":"132","author":"MA Hagenaars","year":"2011","unstructured":"Hagenaars MA, Fisch I, van Minnen A. The effect of trauma onset and frequency on PTSD-associated symptoms. J Affect Disord. 2011;132:192\u20139.","journal-title":"J Affect Disord"},{"key":"3519_CR57","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1037\/a0022121","volume":"4","author":"I Kira","year":"2012","unstructured":"Kira I, Lewandowski L, Somers CL, Yoon JS, Chiodo L. The effects of trauma types, cumulative trauma, and PTSD on IQ in two highly traumatized adolescent groups. Psychol Trauma Theory Res Pract Policy. 2012;4:128\u201339.","journal-title":"Psychol Trauma Theory Res Pract Policy"},{"key":"3519_CR58","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.beth.2010.04.004","volume":"41","author":"T Ehring","year":"2010","unstructured":"Ehring T, Quack D. Emotion regulation difficulties in trauma survivors: the role of trauma type and PTSD symptom severity. Behav Ther. 2010;41:587\u201398.","journal-title":"Behav Ther"},{"key":"3519_CR59","doi-asserted-by":"publisher","first-page":"102133","DOI":"10.1016\/j.janxdis.2019.102133","volume":"67","author":"CL Straud","year":"2019","unstructured":"Straud CL, Siev J, Messer S, Zalta AK. Examining military population and trauma type as moderators of treatment outcome for first-line psychotherapies for PTSD: a meta-analysis. J Anxiety Disord. 2019;67:102133.","journal-title":"J Anxiety Disord"},{"key":"3519_CR60","doi-asserted-by":"publisher","first-page":"119674","DOI":"10.1016\/j.neuroimage.2022.119674","volume":"264","author":"R Radhakrishnan","year":"2022","unstructured":"Radhakrishnan R, Worhunsky PD, Zheng M-Q, Najafzadeh S, Gallezot J-D, Planeta B, et al. Age, gender and body-mass-index relationships with in vivo CB1 receptor availability in healthy humans measured with [11C]OMAR PET. NeuroImage. 2022;264:119674.","journal-title":"NeuroImage"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03519-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03519-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03519-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T12:49:04Z","timestamp":1757422144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03519-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3519"],"URL":"https:\/\/doi.org\/10.1038\/s41398-025-03519-9","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"15 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Bassir Nia is a member of the Scientific Advisory Board of Synendos Therapeutics AG, Switzerland. Dr. Harpaz-Rotem reported receiving grants from Boehringer Ingelheim International GmbH outside the submitted work. No other disclosures were reported.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"310"}}